The human monoclonal antibody S2X259 cross-reacts with spike proteins from all clades of sarbecovirus, and provides prophylactic and therapeutic protection in vivo against parental SARS-CoV-2 and emerging variants of concern.
- M. Alejandra Tortorici
- Nadine Czudnochowski
- Matteo Samuele Pizzuto